osteoporosis » FDA & Pescription Drugs Lawyer New York
Call For A FREE Consultation!
1 (800) 509-2335
You are here: Common Osteoporosis Drugs Could Double Esophageal Cancer Risk
 
Archives by Tag 'osteoporosis'

Common Osteoporosis Drugs Could Double Esophageal Cancer Risk

By Marc J. Bern - Last updated: Friday, September 3, 2010

A new study released Thursday has found that people who take a class of osteoporosis drugs called bisphosphonates such as Actonel (Risedronate), Boniva (Ibandronate) and Fosamax (alendronate) for more than five years may have double the risk of developing cancer of the esophagus. The study entitled “Oral bisphosphonates and risk of cancer of oesophagus, stomach, [...]